Skip to main content
Caplight Logo









Manas AI

Manas AI

Private
New York City, New YorkAI, Data & Cloud Infrastructurehttps://www.manasai.co/

Last Round

Seed

Sep 23, 2025

Total Funding Raised

$50.6M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Manas AI is a biopharmaceutical company that develops an artificial intelligence-driven drug discovery platform designed to accelerate the development of treatments for cancer, autoimmune diseases, and rare conditions.

Sector

AI, Data & Cloud Infrastructure

Verticals

Workflow Automation, Business Intelligence, ML Platforms

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Foundation

Keywords

drug discoverygenerative chemistrybiopharmaceuticalfoundational modelsneuro-symbolic aiai drug discoverymolecular bindingcandidate optimizationtarget identificationbiotech aiphysics-based simulationin silico discoverytherapeutic pipelinefrontier ai lab

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Manas AI Comparables

Compare Manas AI with similar companies based on industry and business-model similarity.

Manas AI comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Numerion Labs
73%
Causaly
36%
EvolutionaryScale
36%

Manas AI Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 23, 2025
SeedJan 27, 2025

Key People

Founding team and executive leadership

Erez Kalir

Chief Operating Officer & Board Member

Executive Team

Manas AI Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 17, 2026

    Grew 23% QoQ, from 26 to 32 employees.

  • May 27, 2026

    Grew 44% QoQ, from 18 to 26 employees.

Manas AI Filings

Explore SEC and related filing metadata, where available.

Manas AI filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Manas AI's valuation, stock price, and market status.

Is Manas AI a public or private company?

Manas AI is a private company.

What is the current stock price of Manas AI?

Manas AI is a private company with no public stock price. No recent secondary market data is available.

How much is Manas AI worth (valuation)?

Valuation information for Manas AI is not publicly available.

Can I buy Manas AI stock?

Manas AI shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Manas AI's last funding round?

Manas AI's most recent funding round was Seed on September 24, 2025.

Who are the main investors in Manas AI?

Key investors in Manas AI include General Catalyst.

Will Manas AI IPO soon?

No public IPO plans have been announced for Manas AI.

How can I track Manas AI secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Manas AI's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNew York City, New York
Employee Range23
Year Founded2025
Last FundingSep 23, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?